DavidMatthewPlattMD

Critical Care Medicine

Vice President and Head, Cardiovascular, Renal & Metabolism Medical Unit, US Clinical Development and Medical Affairs, Novartis

Dr. Platt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
Cedars-Sinai Medical CenterResidency, Internal Medicine, 2001 - 2004
Boston University School of MedicineClass of 2001

PubMed

8 citations
Riociguat improves health-related quality of life for patients with pulmonary arterial hypertension: results from the phase 4 MOTION study:
Namita Sood, Alvaro Aranda, David Platt, Anneliese LaRose, Frank Kleinjung
Pulmonary Circulation. 2019-02-19
24 citations
Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia.
Gustavo A. Heresi, David Platt, Wenyi Wang, Christine Divers, Vijay N. Joish
BMC Pulmonary Medicine. 2017-04-11
61 citations
Deciding in the dark: advance directives and continuation of treatment in chronic critical illness.
Sharon L. Camhi, Alice F. Mercado, R. Sean Morrison, Qingling Du, David Platt
Critical Care Medicine. 2009-03-01

Nature Reviews Drug Discovery Article Offers Independent Support for ProLectin-I in Fibrosis and ProLectin-M as an Antiviral DrugFebruary 22nd, 2023
Galectin Antagonist Use in Mild Cases of SARS-CoV-2: Pilot Feasibility Randomised, Open Label, Controlled Trial Alben Sigamani1*, Mathu Ruthra1, Sudhishma1, Samarth Shetty2, Madhavi2, Anup Chugani3, Hana Chen-Walden4, David Platt4, Thomas Kutty5December 8th, 2020
Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory BoardAugust 1st, 2023